NANOG and non-small cell lung carcinoma: In this study, we show that NSCLC resistance to chemotherapeutic MTA is associated with a stem cell-like phenotype, manifested by an increased level of stem cell factors (Sox2, Oct4 and Nanog) and a greater clonogenicity.